Scientific Founders

Mission Therapeutics was founded by a highly successful team of scientists with a proven track-record in translating new scientific concepts from the laboratory to the clinic and beyond. The team has World-leading scientific knowledge of cellular responses to DNA damage and of how defects in these responses contribute to disease. The ubiquitin pathway and deubiquitylating enzymes (DUBs) are core to these cellular responses.


Professor Steve Jackson

Chief Scientific Officer

After graduating in biochemistry from the University of Leeds followed by a PhD from Edinburgh University, Steve carried out post-doctoral training in the lab of Professor. Robert Tjian at Berkeley, USA. In 1991, he became a…


Dr Niall Martin


Niall Martin graduated with a PhD from Aberdeen University, from where he joined Zeneca Pharmaceuticals as a post-doctoral scientist in the non-lipid cardiovascular disease Bioscience group. In 1993, Niall…


Dr Xavier Jacq


Xavier Jacq obtained his PhD from Louis Pasteur University in Strasbourg, France in 1997. He then carried out post-doctoral training at Columbia University, NY, USA in cancer biology. Following a first industry…


Cancer Research Technology (CRT)

Cancer Research Technology Limited (CRT) is the leading oncology focused technology transfer and development company. CRT sources and develops cancer discoveries from top academics, translating their world-class research into industrial propositions. CRT seeks to identify innovative scientific and business solutions to unmet needs in oncology, partnering with industry to create commercial value and patient benefit from cancer discoveries. For more information, please visit


University of Cambridge

Cambridge Enterprise Ltd. is a wholly owned subsidiary of the University of Cambridge, responsible for the commercialisation of University intellectual property. Activities include management and licensing of intellectual property and patents, proof of concept funding and support for University staff and research groups wishing to provide expert advice or facilities to public and private sector organisations. Cambridge Enterprise provides access to angel and early stage capital through the Cambridge Enterprise Seed Funds and Cambridge Enterprise Venture Partners, and offers business planning, mentoring, and other related programmes. For more information, please visit